JR Baker

T2 A novel drug target: IL-36 signalling drives inflammation and poor bacterial clearance in COPD

HLB Owles, JR Baker, P.S. Fenwick, SL Elkin, KC Kasmi, Peter J Barnes, LE Donnelly (2023). T2 A novel drug target: IL-36 signalling drives inflammation and poor bacterial clearance in COPD. , DOI: https://doi.org/10.1136/thorax-2023-btsabstracts.2.